Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul;59(7):602-7.
doi: 10.1136/thx.2003.018044.

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer

M L G Janssen-Heijnen  1 , S Smulders, V E P P Lemmens, F W J M Smeenk, H J A A van Geffen, J W W Coebergh
Affiliations

Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer

M L G Janssen-Heijnen et al. Thorax. 2004 Jul.

Abstract

Background: With the rising mean age, more patients will be diagnosed with one or more other serious diseases at the time of lung cancer diagnosis. Little is known about the best way to treat elderly patients with comorbidity or the outcome of treatment. This study was undertaken to evaluate the independent effects of age and comorbidity on treatment and prognosis in patients with non-small cell lung cancer (NSCLC).

Methods: All patients with NSCLC diagnosed between 1995 and 1999 in the southern part of the Netherlands (n = 4072) were included.

Results: The proportion of patients with localised NSCLC who underwent surgery was 92% in patients younger than 60 years and 9% in those aged 80 years or older. In patients aged 60-79 years this proportion also decreased with comorbidity. In patients with non-localised NSCLC the proportion receiving chemotherapy was considerably higher for those aged less than 60 years (24%) than in those aged 80 or older (2%). The number of comorbid conditions had no significant influence on the treatment chosen for patients with non-localised disease. Multivariable survival analyses showed that age, tumour size, and treatment were independent prognostic factors for patients with localised disease, and stage of disease and treatment for those with non-localised disease. Comorbidity had no independent prognostic effect.

Conclusions: It is questionable whether the less aggressive treatment of elderly patients with NSCLC is justified.

PubMed Disclaimer

Comment in

  • Surgery in early NSCLC and co-morbidity.
    Sortini D, Pozza E, Maravegias K, Liboni A, Sortini A. Sortini D, et al. Thorax. 2005 Mar;60(3):256; author reply 256-7. Thorax. 2005. PMID: 15741447 Free PMC article. No abstract available.
  • Comorbidity in elderly NSCLC patients.
    Miyazaki K, Kikuchi N, Satoh H, Sekizawa K, Janssen-Heijnen ML, Coebergh JW. Miyazaki K, et al. Thorax. 2005 Aug;60(8):704; author reply 704. doi: 10.1136/thx.2004.039057. Thorax. 2005. PMID: 16061716 Free PMC article. No abstract available.

References

    1. Comput Programs Biomed. 1985;19(2-3):197-207 - PubMed
    1. Ann Hematol. 1999 Jul;78(7):315-9 - PubMed
    1. Eur J Cancer. 2000 Jan;36(1):95-9 - PubMed
    1. Laryngoscope. 2000 Apr;110(4):593-602 - PubMed
    1. Eff Clin Pract. 2001 Jul-Aug;4(4):172-7 - PubMed

Publication types